Stock listing

NASDAQ:NIKI Niki BioSolutions, Inc. Stock

Follow Niki BioSolutions, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:NIKI

$1.57 USD -0.03 (-1.9%)

Close on Nov 20, 2026

Past year -89.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$1.52 – $1.62 USDNov 20, 2026
Volume
6,695 sharesNov 20, 2026
Market cap
$4.61M USDAt the close on Nov 20, 2026 · price × 2.94M shares outstanding
52-week range
$1.42 – $14.40 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$556,708 USDMedian day 18,788 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:NIKI · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.57-0.03-1.9%$1.61$1.624$1.526,695
$1.60+0.10+6.7%$1.505$1.69$1.487,532
$1.50-0.20-11.8%$1.71$1.71$1.504,987
$1.70+0.05+3.0%$1.615$1.70$1.569,579
$1.65-0.05-2.9%$1.711$1.745$1.655,984
$1.70+0.13+8.3%$1.57$1.90$1.50566,677
$1.57-0.04-2.5%$1.60$1.65$1.4418,788
$1.61-0.14-8.0%$1.69$1.71$1.6133,404
$1.75+0.17+10.8%$1.651$1.75$1.65138,266
$1.58+0.08+5.3%$1.48$1.66$1.489,673
$1.50-0.19-11.2%$1.64$1.64$1.4155,286
$1.69-0.07-4.0%$1.75$1.83$1.6869,480
$1.76+0.07+4.1%$1.72$1.80$1.6945,140
$1.69-0.08-4.5%$1.79$1.79$1.6725,505
$1.77-0.186-9.5%$1.81$1.925$1.709,700
$1.956+0.036+1.9%$1.873$1.96$1.815,600
$1.920.000.0%$1.94$2.087$1.785,400
$1.92+0.03+1.6%$1.953$2.141$1.9112,800
$1.89+0.06+3.3%$2.00$2.05$1.8912,600
$1.83-0.03-1.6%$1.94$1.94$1.815,100
$1.86-0.14-7.0%$1.92$1.95$1.8115,000
$2.00-0.03-1.5%$1.91$2.10$1.8310,500
$2.03-0.05-2.4%$2.07$2.14$1.9022,600
$2.08+0.05+2.5%$2.11$2.24$1.919,600
$2.03-0.19-8.6%$2.32$2.40$1.9424,900
$2.22+0.075+3.5%$2.32$2.66$2.1251,900
$2.145-0.48-18.3%$2.58$2.65$2.14521,400
$2.625-0.395-13.1%$2.99$3.22$2.62524,800
$3.02-0.98-24.5%$3.84$3.84$3.0215,800
$4.00-0.32-7.4%$4.12$4.38$4.008,100
$4.32-0.33-7.1%$4.66$4.68$4.1015,900
$4.65-0.31-6.2%$4.62$4.80$4.604,600
$4.96+0.231+4.9%$4.775$4.96$4.697,500
$4.729+0.129+2.8%$4.74$4.79$4.633,700
$4.60-0.21-4.4%$4.71$4.86$4.54512,900
$4.81-0.09-1.8%$5.04$5.17$4.657,900
$4.90+0.16+3.4%$4.81$4.90$4.7824,000
$4.74+0.04+0.9%$4.87$5.00$4.62414,600
$4.70-0.06-1.3%$4.60$4.75$4.5622,100
$4.76-0.21-4.2%$5.08$5.14$4.6658,400
$4.97+0.29+6.2%$4.75$5.00$4.5227,000
$4.68-0.14-2.9%$4.69$4.915$4.687,100
$4.82-0.15-3.0%$4.91$5.14$4.7364,900
$4.97+0.25+5.3%$4.74$5.00$4.6818,800
$4.72-0.54-10.3%$5.23$5.24$4.711136,600
$5.26+0.49+10.3%$4.85$5.29$4.78137,400
$4.77-0.30-5.9%$5.039$5.105$4.64815,800
$5.07-0.77-13.2%$5.82$5.82$5.0544,500
$5.84+0.13+2.3%$5.89$5.89$5.5777,200
$5.71-0.52-8.3%$6.08$6.20$5.6836,600
$6.23+0.22+3.7%$6.00$6.33$5.9144,000
$6.01-0.27-4.3%$6.23$6.47$5.9131,200
$6.28+0.08+1.3%$6.16$6.50$5.91115,600
$6.20-0.31-4.8%$7.15$9.68$6.054,135,100
$6.51-0.10-1.5%$6.48$6.70$6.485,900
$6.61-0.01-0.2%$7.16$7.29$6.5531,200
$6.62-0.24-3.5%$6.89$7.07$6.51116,200
$6.86-0.04-0.6%$6.692$7.15$6.5594,300
$6.90-0.64-8.5%$7.61$7.61$6.9025,900
$7.54-0.305-3.9%$7.74$7.84$7.5014,800
$7.845-0.06-0.8%$7.67$7.88$7.647,700
$7.905-0.105-1.3%$8.14$8.30$7.90522,600
$8.01-0.57-6.6%$8.46$8.61$8.01259,300
$8.58+0.38+4.6%$8.31$9.01$7.7530,500
$8.20+0.05+0.6%$8.20$8.40$8.008,100

Splits

2 splits since 2023 · NASDAQ:NIKI · every price before a split is adjusted for it

DayRatioWhat
1-for-10Consolidation
1-for-10Consolidation
Ticker
NASDAQ:NIKI
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Niki BioSolutions, Inc. news

Niki BioSolutions, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
4 in the last 12 months · 4 in all · newest Nov 9, 2026 · oldest 2026
Decks
17 decks · latest Sep 14, 2026

Valuation

Price/book 0.2× against a median of 0.7×: the lowest of 9 Diagnostics & research services companies shown. Statements: Year to Dec 31, 2025 · price Nov 20, 2026

Enterprise value
$4.60M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
0.2×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.1×
Beta vs S&P 500
1.46

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Niki BioSolutions, Inc. · NASDAQ:NIKIUS$4.61MUS$4.60Mn/an/an/a0.2×n/a0.1×1.46
Nanologica AB · OMXSTO:NICAUS$5.29MUS$8.67M2.9×1.6×n/a0.3×34.9%0.3×n/a
VivoSim Labs, Inc. · NASDAQ:VIVSUS$5.29M−US$2.76Mn/a−20.5×n/a0.7×n/a0.1×1.91
Biomerica, Inc. · NASDAQ:BMRAUS$4.97MUS$2.23Mn/a0.5×n/a1.4×−115.5%0.0×0.71
VolitionRx Limited · AMEX:VNRXUS$4.87MUS$9.19Mn/a2.7×n/an/a−698.5%n/a1.52
Boule Diagnostics AB · OMXSTO:BOULUS$4.84MUS$24.70Mn/a0.6×n/a0.3×−4.0%1.3×n/a
BioInfra Co.,Ltd. · KRX:199730US$4.75M−US$509,202n/a−0.0×n/a0.5×−32.3%0.0×n/a
Cardio Diagnostics Holdings Inc. · NASDAQ:CDIOUS$4.74MUS$4.74Mn/a312×n/a0.8×n/a0.0×2.07
Cambridge Nutritional Sciences PLC · LSE:CNSLUS$4.51MUS$1.23Mn/a0.1×n/a0.6×−83.5%0.0×n/a
Proteome Sciences plc · LSE:PRMUS$4.45MUS$23.87Mn/a4.9×n/an/a−81.5%n/an/a
Immunovia AB · OMXSTO:IMMNOVUS$3.95MUS$2.31Mn/a12.1×n/a6.1×n/a0.4×n/a
Median of the othersUS$4.80MUS$3.52M2.9×1.1×0.7×−81.5%0.1×1.72

Decks

DeckKindSlidesDate
H.C. Wainwright Global Investment Conference, September 2026Conference21 slidesSep 14, 2026
Aptorum Group — HCW Conference September 2025Conference16 slidesSep 10, 2025
Aptorum Group — Technical Presentation (June 2022)Technical18 slidesJun 9, 2022
Aptorum Group — Investor Presentation (June 2022)Investor deck30 slidesJun 9, 2022
Aptorum Group — Investor Presentation (January 2022)Investor deck27 slidesJan 10, 2022
Aptorum Group — Investor Presentation (January 2021)Investor deck24 slidesJan 22, 2021
Aptorum Group — Investor Presentation (October 2020)Investor deck28 slidesOct 20, 2020
Aptorum Group — Investor Presentation (September 2020)Investor deck36 slidesSep 1, 2020
Aptorum Group — Investor Presentation (June 2020)Investor deck33 slidesJun 29, 2020
Aptorum Group — Investor Presentation (February 2020)Investor deck49 slidesFeb 10, 2020
All 17 decks
DeckKindSlidesDate
Aptorum Group — Investor Presentation (October 2019)Investor deck43 slidesOct 25, 2019
Aptorum Group — Investor Presentation (September 2019)Investor deck55 slidesSep 9, 2019
Aptorum Group — Investor Presentation (May 2019)Investor deck12 slidesMay 31, 2019
Aptorum Group — Investor Presentation (May 2019)Investor deck16 slidesMay 31, 2019
Aptorum Group — Investor Presentation (April 2019)Investor deck13 slidesApr 24, 2019
Aptorum Group — Investor Presentation (March 2019)Investor deck36 slidesMar 4, 2019
Aptorum Group — IPO Roadshow (October 2018)IPO roadshow30 slidesOct 10, 2018

Open Decks

IPO

Went public as Aptorum Group Ltd. Priced at US$15.80 a share on Dec 4, 2018.

Price
US$15.80 a share
Shares offered
1,543,245 Class A ordinary shares
Offering size
US$24.4 million · Shares offered times the price, worked out by 6ix
Listing
APM on the Nasdaq Capital Market
Shares delivered
On or about Dec 14, 2018

Steps

StepWhen
Draft sent to the SEC in confidenceJul 13, 2018
Filed publiclySep 5, 2018
Amended 3 timesNewest Nov 28, 2018
Declared effective by the SECDec 3, 2018
Shares registered with an exchangeDec 14, 2018
Final prospectus, with the priceDec 4, 2018

Open IPO · From the cover of the final prospectus (424B4) filed Dec 4, 2018

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue00431.4K1.30M1.54M911.5K535.2K383.4K
Cost of revenue0255.0K420.8K1.22M1.46M1.01M794.5K318.0K58.9K
Gross profit0-255.0K10.6K80.1K81.9K-104.0K-259.0K65.4K-58.9K
Research and development352.9K2.20M5.20M9.22M10.9M11.6M6.94M3.10M2.50M
Selling, general and administrative1.64M1.46M4.37M7.87M8.03M7.71M10.8M6.73M
Operating income-1.82M-3.80M-10.6M-17.5M-19.2M-19.9M-18.2M-10.3M-5.69M
Depreciation and amortization0255.0K1.13M1.21M1.19M1.33M1.30M682.3K58.9K
EBITDA-1.82M-3.54M-9.48M-16.3M-18.0M-18.6M-16.9M-9.65M-5.63M
Interest expense95.7K146.9K121.1K93.6K243.6K3.70M4.46M
Income before tax-1.38M-4.16M-4.34M-11.5M-27.1M4.92M-20.1M-15.1M-2.56M
Income tax-14.0K
Net income-1.36M-4.27M-2.82M-9.80M-25.0M4.92M-20.1M-14.8M-2.55M
Earnings per share, basic-0.19-0.78-0.62-2.75-7.152.03-0.64-0.53-84.56
Earnings per share, diluted-0.19-0.78-0.62-2.75-7.152.00-0.64-0.53

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents3.45M874.2K2.01M1.88M8.13M3.50M5.19M12.0M16.2M
Short-term investments0102.5K236.6K28.4M1.06M1.01M1.97M
Receivables4.54K47.7K174.4K78.7K62.2K40.5K2.83K179.5K
Inventory027.7K35.8K39.1K34.2K30.6K1.54M
Current assets3.59M959.6K2.48M7.07M12.7M33.7M8.03M28.7M20.3M
Property, plant and equipment1.66M2.83M3.73M4.69M7.09M4.26M
Total assets18.7M16.1M20.6M20.9M21.9M44.2M24.0M45.1M31.6M
Accounts payable40.1K
Current liabilities4.59M4.34M2.10M12.5M4.38M3.87M2.67M12.2M1.33M
Long-term debt3.06M129.8K296.2K296.2K294.6K3.42M
Total debt3.44M3.35M3.28M129.8K296.2K296.2K294.6K3.42M480.0K
Total liabilities4.90M4.35M5.26M13.0M4.40M6.08M9.10M12.3M1.33M
Shareholders' equity23.1M21.1M24.8M15.7M23.6M41.8M16.4M33.1M30.2M
Shares outstanding73.5K54.5K45.2K35.7K35.0K31.5K29.0K27.9K30.1K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-1.84M-1.19M-7.72M-12.3M-14.7M-15.9M-13.4M-10.0M-5.78M
Capital spending00-3.02K-186.9K-131.8K-161.3K-837.1K-5.65M-3.06M
Free cash flow-1.84M-1.19M-7.73M-12.5M-14.8M-16.1M-14.2M-15.7M-8.84M
Cash from investing58.6K624.8K2.44M16.5M1.84M-108.1K-6.06M12.8M
Cash from financing4.42M04.09M6.63M2.78M12.4M-7.32M25.5M9.08M
Dividends paid-755.5K
Change in cash2.58M-1.13M-3.01M-3.25M4.64M-1.67M-20.8M9.38M16.1M

Open Financials

Filings

FilingDateTypeFiled with
NT 10-Q · Late filing noticeNov 17, 2026Explanation requestSEC
4 · Change in ownershipNov 17, 2026Insider tradeSEC
3 · Initial statement of ownershipNov 12, 2026Insider tradeSEC
4 · Change in ownershipOct 21, 2026Insider tradeSEC
4 · Change in ownershipOct 21, 2026Insider tradeSEC
4 · Change in ownershipOct 21, 2026Insider tradeSEC
8-K · Current reportOct 13, 2026Management or board changeSEC
EFFECT · Notice that a registration is effectiveOct 13, 2026Other filingsSEC
8-K · Current reportOct 9, 2026Material contractSEC
424B5 · ProspectusOct 9, 2026Offer documentSEC
Show 200 filings
FilingDateTypeFiled with
S-3/A · Registration statement, amendedOct 2, 2026Offer documentSEC
S-3/A · Registration statement, amendedSep 18, 2026Offer documentSEC
8-K · Current reportSep 14, 2026Current reportSEC
8-K · Current reportSep 4, 2026Management or board changeSEC
RW · Request to withdraw a registrationAug 28, 2026Other filingsSEC
S-3 · Registration statementAug 27, 2026Offer documentSEC
8-K/A · Current report, amendedAug 21, 2026Current reportSEC
8-K · Current reportAug 21, 2026Current reportSEC
3 · Initial statement of ownershipAug 13, 2026Insider tradeSEC
3 · Initial statement of ownershipAug 13, 2026Insider tradeSEC
8-K · Current reportAug 7, 2026Current reportSEC
3 · Initial statement of ownershipJul 28, 2026Insider tradeSEC
SCHEDULE 13D · Big-stake noticeJul 24, 2026Big-stake noticeSEC
3 · Initial statement of ownershipJul 24, 2026Insider tradeSEC
3 · Initial statement of ownershipJul 24, 2026Insider tradeSEC
8-K · Current reportJul 20, 2026Acquisition or disposalSEC
6-K/A · Report of a foreign issuer, amendedJun 22, 2026Current reportSEC
6-K · Report of a foreign issuerJun 10, 2026Current reportSEC
424B3 · ProspectusJun 4, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveJun 4, 2026Other filingsSEC
POS AM · Amendment to an effective registrationMay 28, 2026Offer documentSEC
6-K · Report of a foreign issuerMay 14, 2026Current reportSEC
EFFECT · Notice that a registration is effectiveMay 14, 2026Other filingsSEC
S-4/A · Registration statement, amendedMay 8, 2026Offer documentSEC
S-4/A · Registration statement, amendedApr 30, 2026Offer documentSEC
6-K · Report of a foreign issuerMar 31, 2026Current reportSEC
S-4/A · Registration statement, amendedMar 30, 2026Offer documentSEC
20-F · Annual reportMar 27, 2026Annual reportSEC
6-K/A · Report of a foreign issuer, amendedMar 26, 2026Current reportSEC
6-K · Report of a foreign issuerMar 11, 2026Current reportSEC
6-K · Report of a foreign issuerMar 6, 2026Current reportSEC
6-K · Report of a foreign issuerFeb 6, 2026Current reportSEC
6-K · Report of a foreign issuerJan 21, 2026Current reportSEC
S-4/A · Registration statement, amendedJan 21, 2026Offer documentSEC
F-3 · Registration statementJan 16, 2026Offer documentSEC
424B5 · ProspectusDec 5, 2025Offer documentSEC
6-K/A · Report of a foreign issuer, amendedDec 5, 2025Current reportSEC
EFFECT · Notice that a registration is effectiveDec 4, 2025Other filingsSEC
CORRESP · Letter to the SECDec 1, 2025Other filingsSEC
DEL AMNov 18, 2025Other filingsSEC
F-1 · Registration statementNov 17, 2025Offer documentSEC
6-K · Report of a foreign issuerOct 16, 2025Current reportSEC
6-K · Report of a foreign issuerOct 15, 2025Current reportSEC
424B5 · ProspectusOct 14, 2025Offer documentSEC
6-K · Report of a foreign issuerOct 8, 2025Current reportSEC
S-4 · Registration statementOct 6, 2025Offer documentSEC
6-K · Report of a foreign issuerOct 3, 2025Current reportSEC
6-K · Report of a foreign issuerSep 10, 2025Current reportSEC
6-K · Report of a foreign issuerJul 22, 2025Current reportSEC
DRS · Draft registration statementJul 14, 2025Offer documentSEC
DRS · Draft registration statementJul 14, 2025Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
20-F · Annual reportApr 30, 2025Annual reportSEC
6-K · Report of a foreign issuerApr 16, 2025Current reportSEC
SCHEDULE 13G · Big-stake noticeJan 10, 2025Big-stake noticeSEC
6-K · Report of a foreign issuerJan 7, 2025Current reportSEC
SCHEDULE 13G · Big-stake noticeJan 6, 2025Big-stake noticeSEC
424B5 · ProspectusJan 3, 2025Offer documentSEC
6-K · Report of a foreign issuerDec 20, 2024Current reportSEC
6-K · Report of a foreign issuerDec 10, 2024Current reportSEC
6-K · Report of a foreign issuerNov 8, 2024Current reportSEC
6-K · Report of a foreign issuerNov 1, 2024Current reportSEC
6-K/A · Report of a foreign issuer, amendedOct 25, 2024Current reportSEC
6-K · Report of a foreign issuerAug 9, 2024Current reportSEC
S-8 · Registration statement for employee plansJul 26, 2024Offer documentSEC
6-K · Report of a foreign issuerMay 31, 2024Current reportSEC
20-F · Annual reportApr 30, 2024Annual reportSEC
6-K · Report of a foreign issuerApr 30, 2024Current reportSEC
SC 13D/A · Big-stake notice, amendedApr 16, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerMar 6, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedFeb 2, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerDec 22, 2023Current reportSEC
6-K · Report of a foreign issuerDec 21, 2023Current reportSEC
6-K · Report of a foreign issuerNov 30, 2023Current reportSEC
6-K/A · Report of a foreign issuer, amendedNov 21, 2023Current reportSEC
6-K · Report of a foreign issuerNov 16, 2023Current reportSEC
6-K · Report of a foreign issuerSep 11, 2023Current reportSEC
6-K · Report of a foreign issuerAug 10, 2023Current reportSEC
6-K/A · Report of a foreign issuer, amendedJul 14, 2023Current reportSEC
6-K · Report of a foreign issuerJun 30, 2023Current reportSEC
6-K · Report of a foreign issuerJun 30, 2023Current reportSEC
6-K · Report of a foreign issuerJun 9, 2023Current reportSEC
SC 13D/A · Big-stake notice, amendedMay 24, 2023Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveMay 22, 2023Other filingsSEC
POS AM · Amendment to an effective registrationMay 17, 2023Offer documentSEC
424B5 · ProspectusMay 8, 2023Offer documentSEC
6-K · Report of a foreign issuerMay 8, 2023Current reportSEC
6-K · Report of a foreign issuerMay 5, 2023Current reportSEC
424B5 · ProspectusMay 3, 2023Offer documentSEC
6-K · Report of a foreign issuerMay 1, 2023Current reportSEC
6-K · Report of a foreign issuerApr 28, 2023Current reportSEC
20-F · Annual reportApr 28, 2023Annual reportSEC
6-K · Report of a foreign issuerMar 27, 2023Current reportSEC
6-K/A · Report of a foreign issuer, amendedMar 2, 2023Current reportSEC
6-K · Report of a foreign issuerFeb 22, 2023Current reportSEC
6-K · Report of a foreign issuerFeb 10, 2023Current reportSEC
6-K · Report of a foreign issuerFeb 6, 2023Current reportSEC
6-K · Report of a foreign issuerJan 24, 2023Current reportSEC
UPLOAD · Letter from the SECJan 20, 2023Other filingsSEC
6-K · Report of a foreign issuerJan 20, 2023Current reportSEC
EFFECT · Notice that a registration is effectiveJan 20, 2023Other filingsSEC
CORRESP · Letter to the SECJan 17, 2023Other filingsSEC
20-F/A · Annual report, amendedJan 17, 2023Annual reportSEC
CORRESP · Letter to the SECJan 9, 2023Other filingsSEC
UPLOAD · Letter from the SECJan 5, 2023Other filingsSEC
CORRESP · Letter to the SECDec 28, 2022Other filingsSEC
6-K · Report of a foreign issuerDec 22, 2022Current reportSEC
F-3 · Registration statementDec 19, 2022Offer documentSEC
6-K · Report of a foreign issuerDec 16, 2022Current reportSEC
UPLOAD · Letter from the SECDec 15, 2022Other filingsSEC
6-K · Report of a foreign issuerDec 9, 2022Current reportSEC
CORRESP · Letter to the SECDec 2, 2022Other filingsSEC
UPLOAD · Letter from the SECNov 22, 2022Other filingsSEC
6-K · Report of a foreign issuerNov 18, 2022Current reportSEC
6-K · Report of a foreign issuerNov 8, 2022Current reportSEC
6-K · Report of a foreign issuerSep 30, 2022Current reportSEC
6-K · Report of a foreign issuerSep 15, 2022Current reportSEC
6-K · Report of a foreign issuerJul 11, 2022Current reportSEC
6-K · Report of a foreign issuerJun 9, 2022Current reportSEC
EFFECT · Notice that a registration is effectiveJun 7, 2022Other filingsSEC
POS AM · Amendment to an effective registrationJun 1, 2022Offer documentSEC
6-K · Report of a foreign issuerMay 31, 2022Current reportSEC
20-F · Annual reportApr 29, 2022Annual reportSEC
6-K · Report of a foreign issuerApr 29, 2022Current reportSEC
SC 13G · Big-stake noticeFeb 7, 2022Big-stake noticeSEC
6-K · Report of a foreign issuerJan 10, 2022Current reportSEC
6-K · Report of a foreign issuerDec 3, 2021Current reportSEC
6-K · Report of a foreign issuerNov 17, 2021Current reportSEC
6-K · Report of a foreign issuerOct 19, 2021Current reportSEC
6-K · Report of a foreign issuerSep 15, 2021Current reportSEC
6-K · Report of a foreign issuerAug 27, 2021Current reportSEC
SC 13D/A · Big-stake notice, amendedJun 1, 2021Big-stake noticeSEC
6-K · Report of a foreign issuerMay 26, 2021Current reportSEC
424B4 · ProspectusMay 25, 2021Offer documentSEC
EFFECT · Notice that a registration is effectiveMay 18, 2021Other filingsSEC
POS AM · Amendment to an effective registrationMay 14, 2021Offer documentSEC
6-K · Report of a foreign issuerApr 19, 2021Current reportSEC
20-F · Annual reportApr 19, 2021Annual reportSEC
6-K · Report of a foreign issuerMar 26, 2021Current reportSEC
424B5 · ProspectusMar 26, 2021Offer documentSEC
SC 13G · Big-stake noticeFeb 8, 2021Big-stake noticeSEC
6-K · Report of a foreign issuerJan 25, 2021Current reportSEC
6-K · Report of a foreign issuerJan 22, 2021Current reportSEC
6-K · Report of a foreign issuerJan 20, 2021Current reportSEC
6-K · Report of a foreign issuerDec 10, 2020Current reportSEC
6-K · Report of a foreign issuerOct 20, 2020Current reportSEC
6-K · Report of a foreign issuerOct 16, 2020Current reportSEC
6-K · Report of a foreign issuerOct 2, 2020Current reportSEC
424B4 · ProspectusOct 1, 2020Offer documentSEC
EFFECT · Notice that a registration is effectiveSep 30, 2020Other filingsSEC
F-1MEF · Registration of more shares for the same offeringSep 29, 2020Offer documentSEC
CORRESP · Letter to the SECSep 29, 2020Other filingsSEC
CORRESP · Letter to the SECSep 29, 2020Other filingsSEC
CORRESP · Letter to the SECSep 29, 2020Other filingsSEC
F-1/A · Registration statement, amendedSep 28, 2020Offer documentSEC
UPLOAD · Letter from the SECSep 28, 2020Other filingsSEC
CORRESP · Letter to the SECSep 25, 2020Other filingsSEC
F-1/A · Registration statement, amendedSep 25, 2020Offer documentSEC
UPLOAD · Letter from the SECSep 25, 2020Other filingsSEC
CORRESP · Letter to the SECSep 23, 2020Other filingsSEC
F-1/A · Registration statement, amendedSep 23, 2020Offer documentSEC
UPLOAD · Letter from the SECSep 22, 2020Other filingsSEC
F-1 · Registration statementSep 11, 2020Offer documentSEC
6-K · Report of a foreign issuerSep 2, 2020Current reportSEC
6-K · Report of a foreign issuerSep 1, 2020Current reportSEC
6-K · Report of a foreign issuerAug 27, 2020Current reportSEC
6-K · Report of a foreign issuerAug 20, 2020Current reportSEC
6-K · Report of a foreign issuerJul 24, 2020Current reportSEC
6-K · Report of a foreign issuerJul 17, 2020Current reportSEC
6-K · Report of a foreign issuerJun 29, 2020Current reportSEC
6-K · Report of a foreign issuerMay 13, 2020Current reportSEC
20-F · Annual reportApr 29, 2020Annual reportSEC
6-K · Report of a foreign issuerApr 29, 2020Current reportSEC
6-K · Report of a foreign issuerMar 30, 2020Current reportSEC
SC 13D/A · Big-stake notice, amendedMar 10, 2020Big-stake noticeSEC
424B5 · ProspectusFeb 27, 2020Offer documentSEC
6-K · Report of a foreign issuerFeb 26, 2020Current reportSEC
6-K · Report of a foreign issuerFeb 24, 2020Current reportSEC
6-K · Report of a foreign issuerFeb 10, 2020Current reportSEC
EFFECT · Notice that a registration is effectiveJan 16, 2020Other filingsSEC
CORRESP · Letter to the SECJan 14, 2020Other filingsSEC
UPLOAD · Letter from the SECJan 14, 2020Other filingsSEC
6-K · Report of a foreign issuerJan 13, 2020Current reportSEC
F-3 · Registration statementJan 6, 2020Offer documentSEC
RW · Request to withdraw a registrationDec 26, 2019Other filingsSEC
F-3 · Registration statementDec 18, 2019Offer documentSEC
424B3 · ProspectusNov 26, 2019Offer documentSEC
EFFECT · Notice that a registration is effectiveNov 20, 2019Other filingsSEC
6-K · Report of a foreign issuerNov 15, 2019Current reportSEC
POS AM · Amendment to an effective registrationNov 12, 2019Offer documentSEC

This page holds 200 of 261 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Niki BioSolutions, Inc.’s releases

Common shares
2,938,625
Fully diluted
2,938,625

Fully diluted

LineShares
Common shares2,938,625

Share count over time

CountShares
Nov 22, 20262,938,625

Open Cap table

Shareholders

HolderSharesOf the companyValueAs of
Hrt Financial LP15,4620.53%US$75,000Sep 30, 2026
UBS2,1980.07%US$10,770Sep 30, 2026
JPMorgan2<0.01%US$10Sep 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Kira Sheinerman
Other companies: Cardiff Oncology, Inc. (Director · Jun 12, 2008 – Jun 12, 2008 · Past)
Director · Since at least Jul 20, 2026
Alidad MireskandariPresident & COO · Since at least Jul 22, 2026
Laura A PhilipsDirector · Since at least Jul 20, 2026

Open People

Log in to ask 6ix AI your own questions about Niki BioSolutions, Inc.